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10, CH-8093, Zürich, Switzerland
∥Faculty of Engineering and the Environment, and ⊥Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ,
United Kingdom
*S Supporting Information
ABSTRACT: The ability to miniaturize biochemical assays in water-in-oil
emulsion droplets allows a massive scale-down of reaction volumes, so that
high-throughput experimentation can be performed more economically and
more efficiently. Generating such droplets in compartment-on-demand
(COD) platforms is the basis for rapid, automated screening of chemical
and biological libraries with minimal volume consumption. Herein, we
describe the implementation of such a COD platform to perform high
precision nanoliter assays. The coupling of a COD platform to a droplet
absorbance detection set-up results in a fully automated analytical system.
Michaelis−Menten parameters of 4-nitrophenyl glucopyranoside hydrolysis
by sweet almond β-glucosidase can be generated based on 24 time-courses
taken at different substrate concentrations with a total volume consumption
of only 1.4 μL. Importantly, kinetic parameters can be derived in a fully
unsupervised manner within 20 min: droplet production (5 min), initial reading of the droplet sequence (5 min), and droplet
fusion to initiate the reaction and read-out over time (10 min). Similarly, the inhibition of the enzymatic reaction by conduritol B
epoxide and 1-deoxynojirimycin was measured, and Ki values were determined. In both cases, the kinetic parameters obtained in
droplets were identical within error to values obtained in titer plates, despite a >104-fold volume reduction, from micro- to
nanoliters.
Q uantitative assays are at the heart of biological andchemical experimentation. Large numbers of samples
must be interrogated when multiparametric spaces are explored
combinatorially to identify hits that cannot be rationally
predicted, for example, in drug discovery or protein engineer-
ing. Miniaturization of sample sizes and automation of handling
steps are practical imperatives in making this technology
affordable and available to a wider circle of researchers beyond
large companies who are not limited by capital expenditure.
Microfluidic or lab-on-a-chip technologies have shown their
potential in pharmacology, cell biology, and biochemistry.1−4
More recently, droplet-based microfluidics has become an
increasingly powerful tool for reducing and processing reaction
volumes ranging from microliters to nano-, pico-, or even
femtoliters.5−15
Water-in-oil emulsion droplets are generated by mixing an
aqueous and oil phase, using mechanical emulsification or, for
superior control over droplet size and composition, in
microfluidic devices.16 These microcompartments replace the
proverbial test tube (or the more contemporary microwell
plate) as reaction vessels. Current droplet formation
techniques, typically using flow-focusing devices, allow the
generation of very large numbers of droplets at rates in excess
of 10 kHz,17,18 and the setting up of experiments in which large
genetically encoded libraries on the order of ∼106 members can
be analyzed (e.g., in directed evolution).8,11 However, large
numbers of droplets are less useful for experiments in which
smaller libraries (e.g., compound repertoires that have orders of
magnitude fewer library members as compared to genetically
encoded libraries) are used. In these instances, compartment-
on-demand (COD) platforms can provide an alternative to
bulk or flow-focusing droplet formation, and minimize reagent
consumption by sampling material into droplets or plugs at
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significantly lower throughput (1−10 Hz). The lower droplet
production rate presents an opportunity to exert full control
over the sequence and composition of each compartment.
Control over the compartment contents serves as an alternative
to encoding so that labeling steps become superfluous and can
be used for easy production of segmented concentration
gradients. Here, the confidence in the data obtained from each
individual droplet is the crucial basis for the reduction of
droplet numbers (in turn enabling lower reagent consumption)
without loss in information quality.
Several COD platforms have been introduced in the past few
years and applied to combinatorial studies.19,20 On-chip
platforms based on valves21 or high-precision dosing pumps
that allow formation of droplets at the junction of multiple inlet
ports20 have been used to generate microliter droplets with
highly accurate reagent dispensing to generate concentration
gradients of analytes. Other platforms that generate droplets
directly from samples in titer plates in specific sequences use
valves to dispense these “droplet trains” for incubation, which
can be in tubing, or on- chip, and for further analysis.22
Continuous sampling of a PCR assay has been realized using an
automated platform for sample manipulation in which 500 nL
droplets were sequentially formed into a droplet train via a dual
aspirating valve unit for injection into tubing. Using a
commercially available autosampler, kinetic analysis could be
performed by drawing samples to form 5 μL droplets, which
were then split into smaller droplets and mixed with other assay
components to afford final assay droplet volumes of over 800
nL.23 Such valve systems allow control over the sequence of
droplets, but result in large plugs (assay volumes of 800 nL to 5
μL), imply slow droplet generation (up to 30 s for one
droplet), and incur a significant risk of sample contamination
within the valve itself.
A few platforms generate droplets through the use of
negative pressure. For example, the DropLab24,25 and a study
by Wen et al.26 report the suction of aqueous and oil samples to
create concentration gradients via the sequential uptake of the
reagent droplets in the low nanoliter range. In the former work
with DropLab, reagents are mixed by sucking varying ratios of
liquid prior to flow segmentation with oil, whereas the latter
study uses merging elements to combine droplets. Although the
use of negative pressure eliminates the need for valves and
allows formation of much smaller droplets (20 pL to 3 nL),
mixing aqueous solutions in the DropLab system leads to
potential contamination and the initiation of reactions prior to
droplet formation. Conversely, passive on-chip merging allows
precise timing of the fusion event, for example, through pillar
Figure 1. (A) Schematic of the compartment-on-demand platform. Samples (in bottomless tubes) are supplied by rotating an oil-filled carousel.
Samples are withdrawn when a sample tube aligns to PTFE tubing located underneath. Negative pressure is applied via a syringe pump operating in
continuous withdrawal mode, and droplet compartments are generated by moving the tubing up and down between the carrier phase and the
aqueous phase, as shown in (B). The residence time of the hooked end of the tubing in oil or aqueous phase determines the distance between
droplets and the droplet volume, respectively. The absorbance of each microdroplet is read by passage between an LED source aligned with a
photodetector (PD). A typical data trace is shown in the top right (see Figure 2A) showing absorbance data for droplet sequences with different
compounds (corresponding to different colors) and concentration gradients (indicated by shading of each color). (B) Sequential operation of the
COD platform. During all steps of operation, the tubing is aspirating liquid at a constant rate. (i) The tip of the tubing is aligned with a given sample.
(ii) The tip is lifted so that it sits in the aqueous phase of sample 1 (red). (iii) The tip returns to the oil phase. The change from aqueous to oil phase
creates a microcompartment containing a controlled quantity of sample 1 (red). (iv) The tip is aligned below a second sample. (v) The tip is lifted
analogously to step (i), but now sample 2 (blue) is taken up. (vi) The tip comes back to the carrier fluid. As a result of the process shown in (B), a
sequence of microdroplets with defined contents (sample 1, red; sample 2, blue) emerges in the tubing in a preplanned order. Droplets can be
generated at a rate of 0.1−5 s per droplet. No further labeling is necessary as the sequence of sample compartmentalization can be programmed and
droplets appear in the tubing as planned. Control over compartment volume and the distance between compartments is exerted by variation of the
residence times of the tip in aqueous and oil phases.
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designs,27 although these designs restrict to some extent the
range of droplet volumes that can be used.
The current work seeks to overcome the technical complex-
ity of previous COD platforms and to maintain a high-quality
readout, control key operations robotically, and allow
integration with liquid handling system that are commonly
used for compound storage and supply. We achieve alternation
of droplets and controlled merging without the use of valves,
multiple inlets, or a microfluidic chip, with control and
flexibility over the content, size, and number of droplets. The
processes that have to be precisely controlled are the supply of
the compounds tested and their dilution to determine
functional data as a basis for structure−activity relationships.
In our COD platform, a robotic sampler generates a
sequence of microsegments (at a frequency of 0.2 Hz) and
also governs their chemical/biological payload, which can be
varied over a series of compartments. A detection module that
interrogates droplets traveling inside the tubing to give
quantitative absorbance readouts expands the scope of optical
analysis beyond fluorescence. Accordingly, the time-dependent
variation of absorbance as a result of an enzyme-catalyzed
reaction can be determined in a droplet sequence and provides
a quantitative read-out for a series of reagent concentrations.
Reactions were initiated by passive merging of droplets directly
in tubing by acceleration of the flow of droplet pairs placed in
close proximity to each other. Time-courses were extracted by
moving the train of droplets back and forth through the
absorbance detection module. The programmable and robotic
control of the COD platform allows the creation of a sequence
of microfluidic aqueous segments with defined volumes,
frequencies, and interdroplet spacings. High-quality data were
obtained for the enzymatic hydrolysis of 4-nitrophenyl
glucopyranoside by sweet almond β-glucosidase: time-resolved
kinetics for individual droplets with different substrate
concentrations were used to derive kcat and KM values within
20 min in a single run, with full automation from droplet
generation to data collection.
■ RESULTS AND DISCUSSION
A Robotic COD Platform. The COD platform (Figure 1)
creates user-defined sequences of droplets with control over
content and volume. Specifically, it transforms aqueous samples
into individual microcompartments by continuous suction of
fluid into PTFE tubing (200 μm ID) from different samples
loaded in a carousel. Currently, the minimum sample volume
needed to generate droplets is ∼20 μL, which provides a layer
deep enough for the tubing to be immersed while in the “up”
position. To form droplets of a given sample, a solenoid
controlling the vertical motion of the end of a section of tubing
withdraws either oil or sample (placed in bottomless PCR
tubes) from below (Figure 1B), turning the aqueous stream
into an alternating sequence of droplets. In the “down”
position, the tubing is fully immersed in the oil phase, while in
the “up” position, its tip is inside the aqueous phase. The PTFE
tubing and the oil phase are matched in their interfacial
properties, and so upon retraction from the aqueous sample the
tubing is free of any aqueous contamination.
Varying concentration and thus mixing specific volumes of
different reagents requires precise control over droplet size in
our COD platform. To do so, the size of the droplet (created
from the aqueous phase) and the distance between droplets
(created by the oil phase) were controlled by varying the
residence times in each phase. The size of each microsegment
was measured to determine the accuracy of droplet formation,
and observed volumes were compared to theoretical volumes
(Figure S4, Supporting Information). Relative standard
deviations of the droplet lengths were typically less than 10%.
This deviation is caused by the inherent pulsing of the syringe
pump. For kinetic experiments, the actual sizes of droplets
produced were extracted from their “absorbance signature”, and
these values, rather than the theoretically expected volumes,
were used in the determination of kinetic parameters.
Absorbance Measurements. A large number of conven-
tional enzymatic assays rely on UV−Vis spectrophotometric
detection of a chromophore-containing product. Unfortunately,
miniaturization of optical path-lengths results in decreased
absorbance in accordance with the Beer−Lambert law. This is
not a limitation for fluorescence-based measurements, and thus
absorbance detection has only been used sparingly in
microfluidic assays. Examples of such studies include a coupled
assay to measure alcohol oxidation kinetics using disc
microfluidics with a 10 mm path length,28 glucose detection
through a 475 μm-long droplet,29 pH sensing by recording
absorbance movies through a 27 μm optical path,30 and dye
calibration through 500 μm diameter tubing.20 As in the latter
reference, we have implemented absorbance-based detection
using a custom-made polymeric holder that serves to align the
light source and detectors accurately across the tubing. This
configuration bypasses the need for microfluidic chips in which
fibers are embedded31 and provides a simple solution for
optical detection. A typical read-out is shown in Figure 2A.
Fiber core sizes were assessed for their signal-to-noise ratio,
with the optimal design having a core diameter of 200 and 50
μm for connection to the light source and the detector,
respectively. These fiber sizes were used for all subsequent
experiments unless stated otherwise.
On the basis of a typical reading (as shown in Figure 2A),
both the residence time and the average absorbance for each
droplet can be retrieved by postprocessing raw data. On the
basis of the known flow rate, the residence time of a given
droplet across the detection zone can be converted into a
volume (Figure S4). Droplet size was determined using the
edge effects for solutions of low absorbance. In addition, the
average transmittance for PBS buffer alone is higher than the
base transmittance through the oil and was therefore used as a
blank for correction of the absorbance baseline. To assess the
sensitivity and limit of detection of the described implementa-
tion, dilutions of 4-nitrophenol were pipetted into the loading
tubes and transformed into microsegments. Five readings were
taken for each condition and averaged. The absorbance read-
out (Figure 2B) shows excellent linearity (R2 of 0.99) as a
function of dye concentration with a concentration detection
limit approximately 3 μM of 4-nitrophenol (corresponding to
three standard deviations of the background noise). This
compares favorably with other embodiments of absorbance
detection in microfluidic systems (e.g., 13 μM with a 28 μm
path length)32 and, for the assay presented herein, is more than
sufficient to extract quantitative information (from enzyme
turnovers that give rise to product concentrations in the
micromolar to millimolar range).
Creation of Linear Gradients. The creation of controlled
dilution gradients is crucial when performing quantitative assays
that provide accurate enzyme kinetic data for subsequent
structure−activity relationships. To generate linear concen-
tration gradients, microdroplet pairs were generated at a low
flow rate (10−20 nL/s) with the first droplet being smaller than
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the following droplet and separated by a short oil plug. Once all
of the droplet pairs were produced, the flow was halted and
then accelerated to a flow rate of 300 nL/s. This resulted in
paired droplets getting closer to each other, due to an
imbalance of oil leaking through the corner gutters of both
droplets, which behave as leaky pistons.19,20,33 The size of the
oil plug between the two droplets gradually decreased until the
continuous phase completely drains and droplets were able to
coalesce. This process was visualized and is detailed in the
Supporting Information (Figure S5).
By programming the frequency of the up/down motion of
the solenoid, droplet pairs of different size ratios were
generated. Linear gradients were automatically created so that
each droplet pair corresponded to a unique size combination.
The total volume of the merged pairs was kept constant at
approximately 60 nL. In this setup, the time taken to create a
droplet was 0.1−5 s (representing >10-fold faster droplet
generation as compared to DropLab24,25). Using the software
controlling the COD platform, automated generation of 50
droplet pairs and subsequent merging in tubing was shown (see
Figures S7, S8, Supporting Information). Every droplet pair
successfully merged. The parameters for merging were
examined and showed a dependence on the volume of the oil
plug separating droplet pairs with optimal fusion at minimum
oil volume (<5 nL). Moreover, the range over which a
concentration gradient can be produced is defined by the size
ratio between the smaller first droplet and the larger second
droplet. In the current studies, the largest dilution ratio used
was 1:5 with a volume of the smallest droplet of 10 nL. Finally,
it should be noted that the frequently employed method of
serial dilution, that is, multiple sequential dilution steps by the
same factor, makes it hard to obtain as good coverage of a
concentration range as in Figure 3C, which in turn often
precludes acquisition of data good enough for quantitative
analysis in structure−activity relationships.
Programmed Automation. All of the steps including
droplet formation, confirmation and sizing of the droplet
sequence, triggering of the merging, and back and forth
measurement were implemented in a single program. The
schematic of the program is shown in Figure 4.
Enzyme Kinetics in Droplets. The hydrolysis of the
chromogenic substrate 4-nitrophenyl glucopyranoside by sweet
almond β-glucosidase was chosen as a model reaction for
Figure 2. (A) Quantifying absorbance in droplets. A typical trace of an
absorbance read-out (A405 nm) for two droplets (representing sample-
loaded and empty compartments) flowing through a PTFE tubing
(200 μm diameter). The first signal refers to a droplet containing 4-
nitrophenol (2 mM) in PBS buffer, and the second containing buffer
only. Each droplet was interrogated with an LED source with a peak
emission at 405 nm. L defines the residence time of the droplet in the
detection zone and corresponds to the length of the droplet. AA is the
average absorbance of the droplet contents. The recovered signal for
buffer droplets corresponded to the highest voltage and was defined as
zero absorbance (Z). In this example, the continuous oil phase had an
absorbance A405 nm of approximately 0.02. The signal spikes (at the
droplet extremities) are a result of edge effects that are brought about
by refractive index changes between the aqueous and oil phases. (B)
Calibration of the absorbance detection with 4-nitrophenol. Premade
dilutions were introduced into the loading tubes of the carousel, and
the droplet absorbance was read for each condition (n = 5). The data
correlate linearly (R2 of 0.99), and the detection limit (three standard
deviations above the background noise) suggests that measurements
down to 3 μM 4-nitrophenol are possible.
Figure 3. (A) Merging scheme for a pair of microdroplets inside
tubing. A large compartment loaded with enzyme (E) will catch up
with a smaller compartment loaded with substrate (S) placed
immediately in front of it. Merging triggers the hydrolytic reaction
leading to the formation of product P (monitored at 405 nm). (B)
Confirmation and sizing of the droplet sequence. (i) Four sets of six
droplet pairs of enzyme (E) and substrate (10 and 50 mM, referred to
as S10 and S50, respectively) of varying sizes were produced. (ii) The
enzyme/substrate droplets were analyzed shortly after generation, and
prior to merging, to determine the precise size of each droplet. Sizes
were measured by determining the distances Ls (length of the
substrate droplet) and Le (length of the enzyme droplet) as described
previously. The illumination source was a cold white LED, and the
fiber core sizes for illumination and detection were 100 and 50 μm,
respectively. (C) Automated concentration gradient. The substrate
concentration range after mixing of all droplet pairs was 1.3−38.2 mM.
The color code relates the data points in (C) to the primary data in
(B)(i).
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monitoring the action of a typical hydrolytic enzyme and
deriving Michaelis−Menten parameters. Reaction rates with a
range of substrate concentrations were followed over time, and
initial rates, Vo, were determined. Each substrate concentration
corresponds to a combination of enzyme and substrate samples
that are fused in different volume ratios. Two substrate stock
concentrations (10 and 50 mM that are diluted in ratios up to
1:5) were needed to generate a substrate concentration range
between 2 and 40 mM (see Figure 3). These stock solutions
and an enzyme stock (at 78 nM) were loaded in three adjacent
wells in the carousel (Figure 1) and used to generate pairs of
droplets containing enzyme and substrate (Figure 3A). Once all
of the pairs were loaded in sequence, merging was triggered.
The first reading was taken after approximately 30 s (as shown
in Figure 5A). To precisely account for size variation and
confirm that the planned sequence of droplets was indeed
generated, an absorbance detection system was positioned close
to the site of droplet formation to monitor droplet lengths,
which in turn were used to derive the precise enzyme and
substrate concentration for each mixture. This initial reading is
shown in Figure 3B(i), and an expansion showing a single
droplet pair is shown in Figure 3B(ii). The resulting screening
range for substrate concentration is displayed in Figure 3C.
For measuring further time points, two marker droplets
(containing 1 mM 4-nitrophenol) loaded at the front and the
rear of the sequence trigger the automated reversal of the flow
direction. Consequently, the droplet sequence flowed back and
forth passing the absorbance reader. Absorbance measurements
for individual droplets were recorded for each passage through
the detector (Figure S9). These time points were then
assembled into time-courses (Figure 5B) for each droplet in
the known sequence (Figure 5B).
On the basis of the accurate size information for the substrate
and enzyme droplets, the true concentrations of enzyme and
substrate in each reaction droplet were determined and used to
convert the initial rate data shown in Figure 5B into a
Figure 4. The automated workflow programmed to run kinetic assays. Schematic diagram of the four steps that provide a full set of Michaelis−
Menten data: (1) loading of the droplet pairs corresponding to different points of the Michaelis−Menten plot; (2) confirming and sizing of the
droplet pairs prior to fusion; (3) droplet merging in tubing initiates the reaction; and (4) droplets are moved back and forth for reading of the
reaction progress by absorbance. Such readings can be repeated many times until the reaction has advanced sufficiently to describe a full time-course.
The ability to carry out as many measurements as necessary makes this system amenable to most reactions (with time scales from a minute to several
hours or more). The sizing data (step 2) and the data for the time-courses (step 4) were stored in individual files. This process can be repeated for
multiple samples that are sequentially supplied from the carousel of the robotic sampler (Figure 1A).
Figure 5. Derivation of Michaelis−Menten plots from primary data. (A) Confirmation of fusion of droplet pairs and initial assay reading. The first
data point was measured 30 s after initiating the acceleration to cause merging. The LED used for these absorbance measurements emitted at 405
nm. The color code corresponds to the same data points as in Figure 3. (B) Time-resolved measurements of average absorbance value for each assay
point, with corresponding linear fits superimposed. Initial readings were set to zero volts to highlight the diversity of slopes. The color code
corresponds to the droplets displayed in Figures 3B,C and 4A. (C) Michaelis−Menten plot based on 24 substrate concentrations extracted from the
data in (A) and (B). The values for Vo are obtained by converting the voltage change per time into a concentration change per time and then
dividing these values by the enzyme concentration. Colors correspond to the dilution set of Figure 3 and groups of initial rates in Figure 4B. Error
bars shown represent the error in the linear fits shown in Figure 4B.
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Michaelis−Menten plot as shown in Figure 5C. It was found
that in the droplets a background reaction of spontaneous
substrate hydrolysis (at the oil/water interface) gave rise to a
linear increase in product concentration (Figure S10).
Accordingly, the initial slopes were corrected for spontaneous
hydrolysis before conversion to turnover numbers. The data
obtained were modeled with the Michaelis−Menten equation
yielding the kinetic parameters of KM = 11.4 ± 2 mM and kcat =
0.9 ± 0.2 s−1. These values are in close correspondence with
those determined in a microtiter plate (KM = 12.8 ± 4 mM and
kcat = 1.3 ± 0.3 s
−1 (shown in Figure S11)). The total volume
necessary to describe a Michaelis−Menten plot was 720 nL of
enzyme stock and 360 nL for each substrate stock solution (50
and 10 mM).
Inhibition. Our approach was subsequently extended to a
ternary combination of reagents and exemplified with inhibition
studies for a known inhibitor of β-glucosidase, 1-deoxynojir-
imycin hydrochloride (DNM).34 To obtain Michaelis−Menten
kinetic plots in the presence of the inhibitor, different
concentrations of inhibitor and substrate were pipetted into
the loading tubes. Drawing samples from these stocks allowed
easy screening of inhibitor concentrations spanning 3 orders of
magnitude and demonstrated full use of all 15 loading slots in
the current carousel. Here, triplets were created to combine
enzyme, substrate, and inhibitor with the final substrate droplet
representing 50% of the final volume to ensure reproducible
merging of the triplets. A schematic for triplet droplet merging
is shown in Figure 6A. Michaelis−Menten plots for different
inhibitor concentrations are shown in Figure 6B.
Subsequently, rates in the presence of a fixed substrate
concentration and varying concentrations of DNM and
Conduritol B Epoxide (CBE) were measured. We followed
inhibition at high substrate concentrations (23 mM) to
maximize product formation. The ratio between the maximum
initial rate (with no inhibitor) and the initial rate at different
inhibitor concentrations is represented in Figure 6C.
From these data, the IC50 for DNM was determined to be











This inhibition constant corresponds to an approximate Ki
value of 36 μM, assuming competitive inhibition and using the
Cheng−Prusoff equation.36 This correlates well with the
literature value for Ki of 47 μM.
34 The data set for CBE
cannot be used for fitting because CBE is an irreversible
inhibitor, but the observed inhibition is consistent with
microtiter plate readings (cf., Figure S13).37
■ IMPLICATIONS AND CONCLUSIONS
Miniaturization. The COD platform can perform auto-
mated enzyme kinetic experiments without supervision and
generate data comparable in quality to microtiter plate readings,
but works with much smaller quantities of reagents (e.g., 720
nL of enzyme vs 240 μL in a 96-well plate for 24 data points).
Our COD platform also compares favorably with other COD
platforms used for kinetic assays. For example, although the
DropLab24,25 system has been claimed to operate with 2 nL per
reaction (although larger droplets are typically displayed in ref
24) and previously described valve systems23 consume 188 nL
of enzyme per data point, the current COD platform uses an
average of 30 nL of enzyme per data point. Miller et al.35
successfully carried out a screen of small molecule enzyme
inhibitors in 140 pL droplets. However, the confidence in the
data obtained from each single droplet measurement was so
low that more than 10 000 data points were needed to a
construct a reliable binding curve.35 Massive statistical
averaging allowed quantitative interpretation of a scattered
data set to obtain an IC50 value. Our COD system takes the
completely different approach of maximizing the information
extracted per unit volume, so that 500-times fewer data points
are needed. Precise control over droplet size and derivation of
time-courses (rather than single point assays) are responsible
for data quality being equivalent to cuvette or microplate
experiments. This increase in data quality is obtained at the
price of a 5000-fold larger droplet volume (720 nL vs 140 pL),
so that the approach of Miller et al. consumes on balance about
10-times less reagent to obtain a binding curve. When
minimization of reagent consumption is key, this system will
be preferred. Nevertheless, when single species, such as
cells,38−40 of limited availability are to be interrogated (so
that the number of droplets determines their consumption) and
time-dependent data must be obtained, then the current COD
platform becomes the method of choice. Furthermore, the
larger volumes of COD platforms allow absorbance measure-
ments for which the light path in smaller droplets is too short,
enabling a range of assays for which there are no convenient
Figure 6. Determination of inhibition kinetics. (A) Schematic for
triplet droplet merging. (B) Michaelis−Menten plot in the presence of
selected concentrations of 1-deoxynojirimycin hydrochloride (DNM).
The final concentrations of inhibitors were 200 μM (dark gray), 20
nM (cyan), 200 pM (brown), and 0 nM (purple). Here, enzyme
concentration was fixed at 16.5 nM. (C) Normalized rate change V0/
V0
max versus inhibitor concentration for DNM (blue dots) and CBE
(green dots). The data points for DNM were fitted to generate an IC50
(see text for details). For CBE a line was drawn merely to guide the
eye. Conditions: [E] = 19 nM; [S] = 23 mM; [PBS] = 100 mM (pH
7.4).
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fluorescence-based alternatives. Regardless, each of the above
platforms has obvious advantages as compared to typical kinetic
assays in titer-plates: (i) more data points can be obtained with
less reagent (in our case, the volume reduction from microliter
to nanoliter is in excess of 104-fold), (ii) fewer pipetting steps
(20 times fewer for the data shown in this work) are needed as
they are replaced by automated volume calculations and liquid
handling without the expense that industrial facilities attract in
capital expenditure and maintenance; and (iii) single species
experiments can be carried out with data quality that is of
quality similar to that of normal large-scale experiments.
Spatial Encoding. Previous droplet screening systems have
frequently made use of dyes that provided information about
the concentration and/or identity of the contents of the
droplet.23,35,38,41,42 By contrast, no labels are needed in the
described platform, because the sequence of droplets is entirely
programmable. Once the sequence is set, only simple back-and-
forth movements are necessary for detection with no
disturbance in droplet order being observed. The approach of
sequential encoding greatly reduces the technical complexity of
the assay and obviates the need for multiple detection schemes.
Ultimately, reliance on coding dyes will limit the numbers of
compounds that can be screened because there are a finite
number of available dyes that can be optically distinguished.
Before our COD system described here can be applied to a
combinatorial screen, further engineering of the compound
supply (via the carousel and its integration with conventional
liquid handling systems) will be necessary to carry out
automated large-scale experiments.
Droplet Handling without Chips. Performing the entire
assay within tubing eliminates problems tied to integration of
droplet generation and handling in microfluidic chips, such as
the stability of droplet generation or insertion of a sequence of
“droplet trains” through valves. No chips had to be designed
and fabricated for this study, although our system can be easily
integrated with chips while maintaining a specific droplet
sequence, if desired.26 The program that controls robotic
droplet formation is readily adjusted to set the number and size
of the droplets to be merged. Moreover, this work establishes a
new method to merge droplets by exploiting hydrodynamic
flow properties that lead to droplet fusion based on size
difference and does not require additional features provided in
planar chip formats. Relying on full control over droplet size
allows the on-demand generation of varied concentrations of
droplet contents. In the inhibition screen, we describe how we
merged three droplets with premixed inhibitor concentrations
to demonstrate full use of all wells available in the carousel.
However, quadruplet combinations of enzyme, substrate,
inhibitor, and buffer could be merged to create inhibitor
dilutions in a fully automated fashion.
Kinetic Studies in Droplets. Several other droplet systems
have previously been used to measure kinetics, but crucial
differences exist. Song et al.43 demonstrated how control over
the flow rates of the different fluid inlets in a flow-focusing
device can be used to measure fast enzyme kinetics. To obtain
kinetic data with sufficient quality, a dilution stream was imaged
at nine points along the channel with distance corresponding to
the reaction time. Historically, bar a few exceptions,44−46 most
studies in droplets have derived kinetic information from end-
point detection, because series of droplets created at high-
throughput cannot easily be kept in sequence. In these cases,
following a specific droplet over time becomes difficult
(especially when large numbers of repeats are required to
improve data quality). For example, in experiments employing
the DropLab,24,25 only one measurement of product concen-
tration was taken (instead of following reaction turnover as a
function of time), and this one-point measurement provided
the input for a plot that shows the “rate” decrease as a function
of inhibitor concentration. Measuring just one time point to
derive an initial rate is based on the assumption of linearity,
which is only correct when early phases of time-courses are
captured. By contrast, a concentration gradient that is
interrogated during each back-and-forth movement gives access
to full time-course measurements for the same droplet,
improves data quality (by a suitable curve fit through multiple
data points, as in Figure 5B), and allows ready identification of
nonlinearity. The ability to measure absorbance in our format
further increases the versatility of this setup, because the circle
of assays is increased beyond fluorescence that has been the
sole readout in previous platforms.24,25
Outlook. Future challenges will focus on the integration of
this COD platform with analytical interfaces, to extend
compound delivery to multistep processes, and to address
biological experiments that cannot be performed in bulk.
Interfacing with separation techniques such as capillary
electrophoresis47 or analysis by mass spectroscopy48 will
allow a high number of experiments to be examined
sequentially and with minimum supervision. Cell culturing
can also be performed on chip and integrated with droplet
formation.49−51 Sequential robotic delivery of reagents is
important, for example, in ELISA assays52 or other types of
immunoassays and can be programmed into the workflow of
this COD platform. When concentration gradients are set up
for droplets containing single cells or clusters of a few cells that
can be supplied in defined concentrations via Poisson
distribution, quantitative time-dependent experiments will be
carried out on small populations.53 Such an approach would
allow the revalidation of data from microplate cell-based assays
that are only possible with potentially heterogeneous cell
populations.54,55
■ EXPERIMENTAL SECTION
Droplet Generation and Merging. The carousel was
filled with perfluorinated oil (60 mL, FC-40), mixed with
perfluorooctanol (PFO; 0.5%, v/v; Sigma-Aldrich). Samples
were supplied from a carousel that carried up to 15 samples
sitting on a metal ring with 15 holes holding PCR tubes
(Molecular BioProducts, 0.2 mL) that had the bottom 2 mm
sliced off. To generate droplets, PTFE tubing (Ultramicrobore,
0.2 mm ID, 0.4 mm OD, Cole Parmer) was guided by a
stainless steel hook to suck the samples from below (see Figure
S1). To allow digital positioning, the carousel was mounted
onto a stepper-motor allowing precise alignment of the tubing
and sample. Negative pressure was applied from a glass syringe
(200 μL) with a syringe pump operating in withdrawal mode at
constant debit (Chemyx, Fusion 200). Both solenoid and
stepper motor were controlled by a custom-written Labview
program. In a typical experiment, 20−30 droplets were injected
over a distance of 15 cm from the first to last droplet. The
droplet volume was adjusted by variation of the suction flow
rate (originating from the pump) and the dwell time of the
tubing in the aqueous phase (see Figure S4). The Labview
program also controlled merging of droplet pairs and the back-
and-forth flow direction changes for the detection of
absorbance over time.
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Absorbance Measurements. The tubing was aligned with
respect to the fibers via a custom-made polymeric block made
of black acetal. An analog-to-digital board (National Instru-
ments) was used to read voltages from the photodetector.
Typical absorbance readings were taken with a reading rate of
200 Hz using a custom-written Labview program. A low-pass
filter (with a high frequency cutoff at 30 Hz) was applied to all
readings. Using a molar extinction coefficient (ε405 nm) of 13
200 M−1 cm−1 for 4-nitrophenol in PBS, measured in a 1 cm
path length quartz cuvette, the effective average path length
through the droplets was calculated as 151 μm. This value is
consistent with the tube diameter of 200 μm and confirms good
alignment of the tubing and fibers.
■ ASSOCIATED CONTENT
*S Supporting Information
Technical details describing droplet formation, control of
droplet size and merging, as well as comparison of kinetics with
microtiter plate data. Videos are also supplied. This material is
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(48) Küster, S. K.; Fagerer, S. R.; Verboket, P. E.; Eyer, K.; Jefimovs,
K.; Zenobi, R.; Dittrich, P. S. Anal. Chem. 2013, 85, 1285−1280.
(49) Barbulovic-Nad, I.; Au, S. H.; Wheeler, A. R. Lab Chip 2010, 10,
1536−1542.
(50) Hufnagel, H.; Huebner, A.; Gülch, C.; Güse, K.; Abell, C.;
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